Company: NCEL
Filing Date: 2025-02-05
Form Type: F-3
Source: 0001213900-25-010223
Chunk: 40

Company: NewcelX Ltd.
Filing Date: 2025-02-05
Form: F-3
Chunk 40
---
 Shares, consisting of: (i) 161,290 Common Shares issued in a private placement pursuant to the December SPA, (ii) 75,000 Common Shares issued pursuant to the October Debt SPA, and (iii) 408,871 Common Shares issuable upon the conversion of certain of the Company’s PPCs pursuant to the October Debt SPA. All Common Shares, when sold, will be sold by the Selling Shareholder. The Selling Shareholder may sell its Common Shares from time to time at prevailing market prices. We will not receive any proceeds from the sale of the Common Shares by the Selling Shareholder.

| Common                                    
 Shares currently issued and outstanding   |     | 3,597,641 Common Shares.                                                                                                         |
| Common                                    
 Shares offered by the Selling Shareholder |     | 645,161 Common Shares.                                                                                                           |
| Use                                       
 of proceeds                               |     | We will not receive any                                                                                                          
 proceeds from the sale of the Common Shares by the Selling Shareholder.                                                          |
| Risk                                      
 factors                                   |     | Investing in our Common                                                                                                          
 Shares involves a high degree of risk. You should read the “Risk Factors” section starting on page 29 of this prospectus,        
 and other information included or incorporated by reference in this prospectus for a discussion of factors to consider carefully 
 before deciding to invest in the Common Shares.                                                                                  |
| Nasdaq                                    
 Capital Market symbol                     |     | Our Common Shares are listed                                                                                                     
 on the Nasdaq Capital Market under the symbol “NLSP”.                                                                            |

Unless otherwise indicated, the number of Common Shares outstanding prior to and after this offering is based on 3,597,641 Common Shares outstanding, after the approval of the registration of the capital increase on January 7, 2025, and the PPCs and Common Shares issuances to the Selling Shareholder on January 31, 2025, and excludes the following:

| ● | 81,452 PPCs to purchase      
 81,452 of our Common Shares; |

| ● | 1,522,119 warrants to purchase      
 1,522,119 of our Common Shares; and |

| ● | 54,639 options to purchase   
 54,639 of our Common Shares. |

<div align='center'>28

RISK FACTORS</div>

An investment in the Common Shares involves a high degree of risk. We operate in a dynamic and rapidly changing industry that involves numerous risks and uncertainties. You should consider carefully the risk factors described